Cargando…

Metabolic Network Topology of Alzheimer’s Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography

BACKGROUND: Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB) are often misdiagnosed with each other because of similar symptoms including progressive memory loss. The metabolic network topology that describes inter-regional metabolic connections can be generated using fluorodeoxyglucose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imai, Masamichi, Tanaka, Mika, Sakata, Muneyuki, Wagatsuma, Kei, Tago, Tetsuro, Toyohara, Jun, Sengoku, Renpei, Nishina, Yuji, Kanemaru, Kazutomi, Ishibashi, Kenji, Murayama, Shigeo, Ishii, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029362/ https://www.ncbi.nlm.nih.gov/pubmed/31771066 http://dx.doi.org/10.3233/JAD-190843

Ejemplares similares

Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer’s disease: An autopsy-confirmed study
por: Morimoto, Satoru, et al.
Publicado: (2017)

Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [(11)C]CB184, in healthy human volunteers
por: Sakata, Muneyuki, et al.
Publicado: (2017)

Voxel-based morphometry focusing on medial temporal lobe structures has a limited capability to detect amyloid β, an Alzheimer’s disease pathology
por: Kameyama, Masashi, et al.
Publicado: (2020)

Possibility of Enlargement in Left Medial Temporal Areas Against Cerebral Amyloid Deposition Observed During Preclinical Stage
por: Imabayashi, Etsuko, et al.
Publicado: (2022)

CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease
por: Kurihara, Masanori, et al.
Publicado: (2023)

Synthesis and evaluation of N-isopropyl-p-[(11)C]methylamphetamine as a novel cerebral blood flow tracer for positron emission tomography
por: Toyohara, Jun, et al.
Publicado: (2020)

Automated synthesis, preclinical toxicity, and radiation dosimetry of [(18)F]MC225 for clinical use: a tracer for measuring P-glycoprotein function at the blood-brain barrier
por: Toyohara, Jun, et al.
Publicado: (2020)

Direct comparison of brain [(18)F]FDG images acquired by SiPM-based and PMT-based PET/CT: phantom and clinical studies
por: Wagatsuma, Kei, et al.
Publicado: (2020)

Occupancy of α7 Nicotinic Acetylcholine Receptors in the Brain by Tropisetron: A Positron Emission Tomography Study Using [(11)C]CHIBA-1001 in Healthy Human Subjects
por: Ishikawa, Masatomo, et al.
Publicado: (2011)

Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases
por: Tanei, Zen-ichi, et al.
Publicado: (2020)

Adenosine A(2A) Receptor Occupancy by Long‐Term Istradefylline Administration in Parkinson's Disease
por: Ishibashi, Kenji, et al.
Publicado: (2020)

Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
por: Ishibashi, Kenji, et al.
Publicado: (2022)

Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer's disease: A study using (11)C-ITMM positron emission tomography
por: Ishibashi, Kenji, et al.
Publicado: (2019)

Autopsy Validation of the Diagnostic Accuracy of (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease
por: Matsubara, Tomoyasu, et al.
Publicado: (2022)

Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using (18)F-THK5351 positron emission tomography
por: Ishibashi, Kenji, et al.
Publicado: (2020)

(18)F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies
por: Graff-Radford, Jonathan, et al.
Publicado: (2020)

High sensitivity of asymmetric (18)F-THK5351 PET abnormality in patients with corticobasal syndrome
por: Kurihara, Masanori, et al.
Publicado: (2023)

Changes in cerebral blood flow during steady-state cycling exercise: a study using oxygen-15-labeled water with PET
por: Hiura, Mikio, et al.
Publicado: (2014)

Age-Related Decrease in Male Extra-Striatal Adenosine A(1) Receptors Measured Using (11)C-MPDX PET
por: Mishina, Masahiro, et al.
Publicado: (2017)

In Vivo Evaluation of α7 Nicotinic Acetylcholine Receptor Agonists [(11)C]A-582941 and [(11)C]A-844606 in Mice and Conscious Monkeys
por: Toyohara, Jun, et al.
Publicado: (2010)

Imaging spectrum of sporadic cerebral amyloid angiopathy: multifaceted features of a single pathological condition
por: Sakurai, Keita, et al.
Publicado: (2014)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases
por: Tago, Tetsuro, et al.
Publicado: (2018)

Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson’s disease and multiple system atrophy: a case report
por: Ishibashi, Kenji, et al.
Publicado: (2015)

Great Psychological Distress Induced by COVID-19 on Healthcare Workers in Japan
por: Sengoku, Renpei
Publicado: (2021)

Occipital and Cingulate Hypometabolism are Significantly Under-Reported on 18-Fluorodeoxyglucose Positron Emission Tomography Scans of Patients with Lewy Body Dementia
por: Hamed, Moath, et al.
Publicado: (2018)

The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome
por: Sakurai, Keita, et al.
Publicado: (2014)

Usefulness of (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma
por: Yokose, Takahiro, et al.
Publicado: (2020)

Diagnostic Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Gastric Mesenchymal Tumors
por: Iwamuro, Masaya, et al.
Publicado: (2020)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Binding of Pramipexole to Extrastriatal Dopamine D(2)/D(3) Receptors in the Human Brain: A Positron Emission Tomography Study Using (11)C-FLB 457
por: Ishibashi, Kenji, et al.
Publicado: (2011)

Reduction of the fluorine-18-labeled fluorodeoxyglucose dose for clinically dedicated breast positron emission tomography
por: Satoh, Yoko, et al.
Publicado: (2019)

(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging evaluation of chorea
por: Ishii, Nobuyuki, et al.
Publicado: (2018)

(18)F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
por: Horikoshi, Hideyuki, et al.
Publicado: (2020)

Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer’s disease
por: Imabayashi, Etsuko, et al.
Publicado: (2022)

Tau and TDP-43 accumulation of the basal nucleus of Meynert in individuals with cerebral lobar infarcts or hemorrhage
por: Hatsuta, Hiroyuki, et al.
Publicado: (2019)

18F‐fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma
por: Nomura, Kotaro, et al.
Publicado: (2022)

PET Imaging of (18)F-FDG, (11)C-methionine, (11)C-flumazenil, and (11)C-4DST in Progressive Multifocal Leukoencephalopathy
por: Ishibashi, Kenji, et al.
Publicado: (2017)

Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders
por: Araki, Wataru, et al.
Publicado: (2017)

Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography
por: Suzumura, Kazuhiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8fvur7ho2l5iladmjnnee1v44o